Page last updated: 2024-08-24

2'-deoxyuridylic acid and brivudine

2'-deoxyuridylic acid has been researched along with brivudine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agrofoglio, LA; Alexandre, JA; Andrei, G; Azzouzi, A; Balzarini, J; Broggi, J; Caillat, C; Deville-Bonne, D; El-Amri, C; Eriksson, S; Lin, J; Meyer, P; Pradère, U; Roy, V; Snoeck, R; Topalis, D	1
Beryt, M; Boyer, C; Groziak, MP; Johnston, P; Lackey, DB; Park, JW; Pegram, M; Sayre, P; Sergeeva, M; Shepard, HM; Slamon, D; Stroud, RM	1

Other Studies

2 other study(ies) available for 2'-deoxyuridylic acid and brivudine

Article	Year
Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. Journal of medicinal chemistry, 2011, Jan-13, Volume: 54, Issue:1 Topics: Antiviral Agents; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Herpesviridae; Humans; Ligands; Models, Molecular; Molecular Structure; Nucleoside-Phosphate Kinase; Organophosphonates; Prodrugs; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity; Thymidine; Thymidine Kinase	2011
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase. Biochemical pharmacology, 2001, Jan-15, Volume: 61, Issue:2 Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Deoxyuracil Nucleotides; Disease Models, Animal; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Prodrugs; Thymidylate Synthase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001

Article

Year

Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates.

Journal of medicinal chemistry, 2011, Jan-13, Volume: 54, Issue:1

Topics: Antiviral Agents; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Herpesviridae; Humans; Ligands; Models, Molecular; Molecular Structure; Nucleoside-Phosphate Kinase; Organophosphonates; Prodrugs; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity; Thymidine; Thymidine Kinase

2011

Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.

Biochemical pharmacology, 2001, Jan-15, Volume: 61, Issue:2

Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Deoxyuracil Nucleotides; Disease Models, Animal; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Prodrugs; Thymidylate Synthase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001